In order to improve treatments for prostate cancer, researchers must understand and properly evaluate patient responses to current options. A clinical trial led by Deborah E. Citrin, M.D., Senior Investigator in the Radiation Oncology Branch, is using prostate-specific membrane antigen (PSMA) imaging to evaluate the efficacy of radiation treatment in patients with prostate cancer. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.
Clinicaltrials.gov identifier: NCT05155046
NCI Protocol ID: NCI000481
Official Title: Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.